摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-Phenylpropyl)-isonipecotinsaeure-ethylester | 21327-50-4

中文名称
——
中文别名
——
英文名称
1-(3-Phenylpropyl)-isonipecotinsaeure-ethylester
英文别名
Ethyl 1-(3-phenylpropyl)piperidine-4-carboxylate
1-(3-Phenylpropyl)-isonipecotinsaeure-ethylester化学式
CAS
21327-50-4
化学式
C17H25NO2
mdl
——
分子量
275.391
InChiKey
SSDDQYAUQSKHRP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    20
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:2c8b9386b0bd94ab9c19ae04c7690933
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(3-Phenylpropyl)-isonipecotinsaeure-ethylester 在 lithium aluminium tetrahydride 、 对甲苯磺酸 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 生成 4-[Bis-(4-fluoro-phenyl)-methoxymethyl]-1-(3-phenyl-propyl)-piperidine
    参考文献:
    名称:
    新型4- [2- [2- [双(4-氟苯基)甲氧基]乙基] -1-(3-苯基丙基)哌啶类似物的结构活性关系研究:在多巴胺和5-羟色胺转运蛋白位点的合成和生物学评估。
    摘要:
    制备了强效多巴胺(DA)转运蛋白配体4- [2- [双(4-氟苯基)-甲氧基]乙基] -1-(3-苯基丙基)哌啶的类似物1b,并对其在生物学上的结合进行了生物学评估。大鼠纹状体膜中的DA和血清素(5HT)转运蛋白。在这些分子中引入了不同的烷基链长度和取代基,以产生针对DA转运蛋白的最佳活性和选择性。通常,未取代的和氟取代的化合物对于DA转运蛋白是最活跃和最具选择性的。化合物4- [2-(二苯基甲氧基)乙基] -1-苄基哌啶9a显示出高效价,并且在该系列化合物中对DA转运蛋白的选择性最高(5HT / DA = 49)。发现其中一些新颖的类似物比原始GBR 12909分子在DA转运蛋白上的结合更具选择性,
    DOI:
    10.1021/jm9506581
  • 作为产物:
    描述:
    哌啶-4-甲酸乙酯1-氯-3-苯基丙烷三乙胺 作用下, 以 甲苯 为溶剂, 以65%的产率得到1-(3-Phenylpropyl)-isonipecotinsaeure-ethylester
    参考文献:
    名称:
    Cignarella; Villa; Barlocco, Il Farmaco, 1993, vol. 48, # 10, p. 1439 - 1445
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs
    作者:Paul J. Gilligan、Gary A. Cain、Thomas E. Christos、Leonard Cook、Spencer Drummond、Alexander L. Johnson、Ahmed A. Kergaye、John F. McElroy、Kenneth W. Rohrbach
    DOI:10.1021/jm00101a012
    日期:1992.11
    Sigma receptor ligands represent a new class of potential antipsychotic drugs. This paper presents the structure-activity relationships leading to novel disubstituted piperidine sigma ligands, which have little or no affinity for dopamine D2 receptors. Selectivity for sigma sites over dopamine D2 or serotonin 5-HT2 receptors appears to be governed by the chemical nature of the piperidine nitrogen substituent, its distance from the basic nitrogen, and its orientation relative to the other piperidine substituent. Several of these compounds have good oral potency in some animal models used to evaluate potential antipsychotic drugs. The N-cyclopropylmethyl ketones and ethers (e.g. 6i (DuP 734), 6q, 18a, and 18n) have the best in vivo potency. Compounds 6i (DuP 734) and 6q did not cause catalepsy in the rat, even at very high doses. On the basis of the pharmacology profiles of these sigma ligands, we propose these compounds may be effective antipsychotic drugs, which do not induce extrapyramidal side effects or tardive dyskinesia.
  • Identification of novel scaffolds for potential anti- Helicobacter pylori agents based on the crystal structure of H. pylori 3-deoxy- d -manno-octulosonate 8-phosphate synthase ( Hp KDO8PS)
    作者:Sujin Cho、Hookang Im、Ki-Young Lee、Jie Chen、Hae Ju Kang、Hye-Jin Yoon、Kyung Hoon Min、Kang Ro Lee、Hyun-Ju Park、Bong-Jin Lee
    DOI:10.1016/j.ejmech.2015.11.036
    日期:2016.1
    The crystal structure of 3-deoxy-D-manno-octulosonate-8-phosphate synthase (KDO8PS) from Helicobacter pylori (HpKDO8PS) was determined alone and within various complexes, revealing an extra helix (HE) that is absent in the structures of KDO8PS from other organisms. In contrast to the metal coordination of the KDO8PS enzyme from Aquifex aeolicus, HpKDO8PS is specifically coordinated with Cd2+ or Zn2+ ions, and isothermal titration calorimetry (ITC) and differential scanning fluorimetry (DSF) revealed that Cd2+ thermally stabilizes the protein structure more efficiently than Zn2+. In the substrate bound structure, water molecules play a key role in fixing residues in the proper configuration to achieve a compact structure. Using the structures of HpKDO8PS and API [arabinose 5 -phosphate (A5P) and phosphoenolpyruvate (PEP) bisubstrate inhibitor], we generated 21 compounds showing potential HpKDO8PS-binding properties via in silico virtual screening. The capacity of three, avicularin, hyperin, and MC181, to bind to HpKDO8PS was confirmed through saturation transfer difference (STD) experiments, and we identified their specific ligand binding modes by combining competition experiments and docking simulation analysis. Hyperin was confirmed to bind to the A5P binding site, primarily via hydrophilic interaction, whereas MC181 bound to both the PEP and A5P binding sites through hydrophilic and hydrophobic interactions. These results were consistent with the epitope mapping by STD. Our results are expected to provide clues for the development of HpKDO8PS inhibitors. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Structure−Activity Relationship Studies of Novel 4-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-1-(3-phenylpropyl)piperidine Analogs:  Synthesis and Biological Evaluation at the Dopamine and Serotonin Transporter Sites
    作者:Aloke K. Dutta、Cen Xu、Maarten E. A. Reith
    DOI:10.1021/jm9506581
    日期:1996.1.1
    Several analogs of the potent dopamine (DA) transporter ligand 4-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-1-(3-phenylpropyl)piperidine, 1b, were made and biologically evaluated for their binding at the DA and serotonin (5HT) transporters in rat striatal membranes. Different alkyl chain lengths and substitutions were introduced in these molecules to generate an optimum activity and selectivity for the
    制备了强效多巴胺(DA)转运蛋白配体4- [2- [双(4-氟苯基)-甲氧基]乙基] -1-(3-苯基丙基)哌啶的类似物1b,并对其在生物学上的结合进行了生物学评估。大鼠纹状体膜中的DA和血清素(5HT)转运蛋白。在这些分子中引入了不同的烷基链长度和取代基,以产生针对DA转运蛋白的最佳活性和选择性。通常,未取代的和氟取代的化合物对于DA转运蛋白是最活跃和最具选择性的。化合物4- [2-(二苯基甲氧基)乙基] -1-苄基哌啶9a显示出高效价,并且在该系列化合物中对DA转运蛋白的选择性最高(5HT / DA = 49)。发现其中一些新颖的类似物比原始GBR 12909分子在DA转运蛋白上的结合更具选择性,
  • Cignarella; Villa; Barlocco, Il Farmaco, 1993, vol. 48, # 10, p. 1439 - 1445
    作者:Cignarella、Villa、Barlocco
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐